SteelPeak Wealth LLC Buys 41,761 Shares of Astrana Health, Inc. $ASTH

SteelPeak Wealth LLC raised its stake in shares of Astrana Health, Inc. (NASDAQ:ASTH) by 7.8% in the third quarter, Holdings Channel reports. The institutional investor owned 579,937 shares of the company’s stock after buying an additional 41,761 shares during the quarter. SteelPeak Wealth LLC’s holdings in Astrana Health were worth $16,441,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of ASTH. Royal Bank of Canada boosted its position in shares of Astrana Health by 6.5% in the first quarter. Royal Bank of Canada now owns 278,619 shares of the company’s stock valued at $8,640,000 after acquiring an additional 17,028 shares during the period. Jacobs Levy Equity Management Inc. lifted its stake in Astrana Health by 211.6% in the 1st quarter. Jacobs Levy Equity Management Inc. now owns 237,926 shares of the company’s stock worth $7,378,000 after purchasing an additional 161,580 shares in the last quarter. Rhenman & Partners Asset Management AB boosted its holdings in Astrana Health by 26.7% in the 2nd quarter. Rhenman & Partners Asset Management AB now owns 190,000 shares of the company’s stock valued at $4,727,000 after purchasing an additional 40,000 shares during the period. Pacer Advisors Inc. bought a new position in Astrana Health in the 3rd quarter valued at $5,157,000. Finally, Public Sector Pension Investment Board grew its position in shares of Astrana Health by 7.4% during the 2nd quarter. Public Sector Pension Investment Board now owns 141,541 shares of the company’s stock valued at $3,522,000 after purchasing an additional 9,730 shares in the last quarter. 52.77% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

ASTH has been the topic of a number of recent analyst reports. Zacks Research lowered Astrana Health from a “hold” rating to a “strong sell” rating in a research note on Monday, November 10th. Jefferies Financial Group reaffirmed a “buy” rating on shares of Astrana Health in a report on Tuesday, November 25th. BTIG Research cut their price objective on Astrana Health from $50.00 to $45.00 and set a “buy” rating for the company in a report on Friday, November 7th. Barclays decreased their price objective on shares of Astrana Health from $36.00 to $26.00 and set an “equal weight” rating on the stock in a research report on Monday, November 24th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Astrana Health in a research note on Monday. Eight investment analysts have rated the stock with a Buy rating, one has given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, Astrana Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $41.33.

Astrana Health Price Performance

Shares of Astrana Health stock opened at $24.81 on Friday. The firm has a market capitalization of $1.40 billion, a PE ratio of 130.59, a price-to-earnings-growth ratio of 1.50 and a beta of 0.86. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.27. Astrana Health, Inc. has a 12 month low of $20.12 and a 12 month high of $39.97. The business’s 50-day moving average price is $25.06 and its 200-day moving average price is $26.65.

Astrana Health (NASDAQ:ASTH) last released its earnings results on Wednesday, January 10th. The company reported $0.50 earnings per share for the quarter. Astrana Health had a return on equity of 1.26% and a net margin of 0.33%.The company had revenue of $317.00 million during the quarter. Sell-side analysts forecast that Astrana Health, Inc. will post 1.15 EPS for the current fiscal year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.